Stockscreener 앱 받기
1.96
2.00%
-0.04
시간 외 거래:
1.96
전일 마감가:
$2.00
열려 있는:
$1.96
하루 거래량:
49,824
Relative Volume:
0.53
시가총액:
$67.45M
수익:
-
순이익/손실:
$-14.47M
주가수익비율:
-1.5806
EPS:
-1.24
순현금흐름:
$-12.19M
1주 성능:
+1.03%
1개월 성능:
-2.97%
6개월 성능:
-17.30%
1년 성능:
-6.22%
1일 변동 폭
$1.9401
$2.05
1주일 범위
$1.85
$2.05
52주 변동 폭
$1.70
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.96 | 67.45M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
226.50 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.95 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.89 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.74 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.33 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
Benchmark maintains $8 target on Heartbeam stock post-Q4 report - Investing.com
Benchmark maintains $8 target on Heartbeam stock post-Q4 report By Investing.com - Investing.com South Africa
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System - Business Wire
HeartBeam reports net loss of USD 4.9M in Q4 2024 - Medical Buyer
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Earnings Call Transcript - Insider Monkey
HeartBeam’s Earnings Call Highlights Strategic Progress - TipRanks
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress - The Globe and Mail
HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves By GuruFocus - Investing.com Canada
HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations - TipRanks
Earnings call transcript: HeartBEAM Q4 2024 misses EPS forecasts - Investing.com
HeartBeam Reports Fourth Quarter and Full Year 2024 Results -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2024 Results - Business Wire
HeartBeam (NASDAQ: BEAT) To Present At Upcoming Investor And Industry Conferences - Barchart
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 - The Bakersfield Californian
Meet HeartBeam Executives: Key Investment Conferences Set for California Next Month - StockTitan
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time - The Bakersfield Californian
HeartBeam (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M - The Globe and Mail
HeartBeam closes underwriter’s over-allotment option for PO - Medical Buyer
HeartBeam Raises $11.5M: What This Capital Injection Means for Its Commercial Launch Timeline - StockTitan
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock - Investing.com India
Heartbeam director Richard Ferrari buys $50,000 in stock By Investing.com - Investing.com Australia
Heartbeam director Richard Ferrari buys $50,000 in stock - Investing.com India
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock By Investing.com - Investing.com Nigeria
HeartBeam announces pricing of UPO - Medical Buyer
HeartBeam submits 510(k) application to FDA for ECG software - MSN
HeartBeam sets price for $10 million stock offering - MSN
HeartBeam prices public offering of 5.88M shares; shares down - MSN
HeartBeam Secures Major Funding: FDA-Cleared Cardiac Innovation Gets $10M Boost - StockTitan
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software - The Globe and Mail
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Submits 12-Lead ECG Synthesis Software to FDA - MPO-mag
BEATHeartbeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software - Business Wire
Blaize Appoints Yoshiaki Fujimori and George de Urioste to Board of Directors - Business Wire
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
2.27%
자본화:
|
볼륨(24시간):